PA

ParcelBio

YC W24

San Francisco, US · Founded 2023 · 6 employees · 4 known investors

parcelbio.com ↗

ParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies. The platform targets autoimmune disease, oncology, and therapeutic protein replacement applications.

Founders & leadership· Y Combinator alumni (W24)

David WeinberginFounder

Chris CarlsoninFounder

Investors · 4

Y

Y Combinator✓ verifiedMountain View · $500K – $500K

BR

Breyer Capital✓ verified

GE

General Catalyst✓ verifiedSan Francisco

RI

Ritual CapitalMenlo Park · $100K – $500K